These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4358435)

  • 21. Mechanism of the antihypertensive effect of TR2515, a potent serotonin antagonist.
    Hong E; Rion R; Rojas G
    Proc West Pharmacol Soc; 1984; 27():1-4. PubMed ID: 6494139
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of quinidine on vascular resistance and sympathetic nerve activity in humans.
    Mariano DJ; Schomer SJ; Rea RF
    J Am Coll Cardiol; 1992 Nov; 20(6):1411-6. PubMed ID: 1430692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the effect of apomorphine on the skin and muscle circulation of man].
    Konzett H; Strieder N
    Z Kreislaufforsch; 1969 Feb; 58(2):210-4. PubMed ID: 5793647
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperaemic responses in two vascular beds of the anaesthetised cat.
    Hamilton TC
    Arch Int Pharmacodyn Ther; 1976 Feb; 219(2):230-42. PubMed ID: 1275617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of adrenergic potentiating effect of angiotensin by 1-Sar-8-Ala-angiotensin II.
    Zimmerman BG
    J Pharmacol Exp Ther; 1973 Jun; 185(3):486-92. PubMed ID: 4351403
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of prostaglandins B1 and B2 on vasoconstrictor responses of the canine hindpaw.
    Greenberg S; Howard L; Engelbrecht J; Wilson WR
    J Pharmacol Exp Ther; 1974 Jul; 190(1):70-6. PubMed ID: 4847313
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanism of the vasoconstrictor action of prostaglandin B.
    Greenberg S; Wilson WR; Howard L
    J Pharmacol Exp Ther; 1974 Jul; 190(1):59-69. PubMed ID: 4211165
    [No Abstract]   [Full Text] [Related]  

  • 28. Dose-response effects of quinidine on electrophysiological properties of the heart.
    Duncan RJ; Nash CB
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):358-67. PubMed ID: 5070647
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of captopril on sympathetic control of the heart and vasculature in dogs.
    Vollmer RR; Horovitz ZP; Harris DN; Murthy VS
    Clin Exp Hypertens A; 1987; 9(12):2095-111. PubMed ID: 3325200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular smooth muscle. II. Pharmacology of normal and hypotensive vessels.
    Somlyo AP; Somlyo AV
    Pharmacol Rev; 1970 Jun; 22(2):249-353. PubMed ID: 4393387
    [No Abstract]   [Full Text] [Related]  

  • 31. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
    Mitchell A; Rushentsova U; Siffert W; Philipp T; Wenzel RR
    Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of the inability of cocaine to potentiate the responses to cardiac sympathetic nerve stimulation in the dog.
    Koerker RL; Moran NC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):482-96. PubMed ID: 5571899
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of prostaglandins E 1 , E 2 and A 2 on vascular resistance and responses to noradrenaline, nerve stimulation and angiotensin in the dog hindlimb.
    Kadowitz PJ
    Br J Pharmacol; 1972 Nov; 46(3):395-400. PubMed ID: 4348179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197).
    Privitera PJ; Blickenstaff T; Gaffney TE; Mohammed S
    J Pharmacol Exp Ther; 1971 Mar; 176(3):655-61. PubMed ID: 4398744
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of vascular resistance changes produced in skin and muscle by halothane.
    Akester JM; Brody MJ
    J Pharmacol Exp Ther; 1969 Dec; 170(2):287-93. PubMed ID: 4311321
    [No Abstract]   [Full Text] [Related]  

  • 37. Blockade of adrenergic vasoconstrictor responses in the dog by prostaglandins E 1 and A 1 .
    Kadowitz PJ; Sweet CS; Brody MJ
    J Pharmacol Exp Ther; 1971 Dec; 179(3):563-72. PubMed ID: 4333025
    [No Abstract]   [Full Text] [Related]  

  • 38. Carotid chemoreceptor modulation of regional blood flow distribution during exercise in health and chronic heart failure.
    Stickland MK; Miller JD; Smith CA; Dempsey JA
    Circ Res; 2007 May; 100(9):1371-8. PubMed ID: 17431189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homologous upregulation of human arterial alpha-adrenergic responses by guanadrel.
    Hogikyan RV; Supiano MA
    J Clin Invest; 1993 Apr; 91(4):1429-35. PubMed ID: 8473492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of neural and thermal vasoconstriction by prostaglandin B1.
    Engelbrecht JA; Greenberg S; Wilson WR
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):729-33. PubMed ID: 805432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.